Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

Large granular lymphocytic leukemias (LGLLs) are a heterogeneous group of rare chronic lymphoproliferative disorders ...

CERo Therapeutics (CERO) announces the allowance of two patent applications submitted to the U.S. Patent and Trademark Office, USPTO, which ...

Investing.com — CERo Therapeutics Holdings, Inc. (NASDAQ: CERO )，一家专注于工程化T细胞免疫疗法的公司，目前市值为160万美元，宣布美国专利商标局 (USPTO)已批准其两项关键专利申请，标志着其知识产权的显著扩展。根据 InvestingPro ...

Large granular lymphocytic leukemias (LGLLs) are a heterogeneous group of rare chronic lymphoproliferative disorders characterized by the clonal ...

Hosted by BioBuzz, BitsInBio, Atria, and Zetta, AI x Bio Philly brought together innovators, entrepreneurs, and investors for an evening of demos, discussion, and insight into how AI is shaping the ...

Oncolytic adenovirus was engineered for the forced ectopic delivery of peptide-MHC ligand of T cell receptors (TCRs) to ...

T细胞在细胞免疫和免疫调节以及适应性免疫中起着重要作用。PD-1在T细胞活化、耐受和耗竭中起着至关重要的作用，并参与肿瘤发生、炎症和感染。T细胞上PD-1的异常表达破坏了免疫稳态，并为疾病发展创造了机会。

智通财经APP获悉，4月2日，中国国家药监局药品审评中心(CDE)官网公示，阿斯利康(AZN.US)申报的1类新药AZD5492在中国获批两项新的临床试验默示许可，拟用于治疗系统性红斑狼疮、特发性炎症性肌病。公开资料显示，这是一款CD20×TCR×C ...

推荐语：本研究揭示了TCR-pMHC-CD8三分子复合物在机械力调控下的"捕获-滑动"键动态特性，解决了高亲和力TCR工程中自身肽交叉反应性的难题。作者通过单分子生物力学、MD模拟等技术，发现CD8通过力依赖的构象变化增强TCR对激动肽的识别，而过度强化的TCR-pMHC结合 ...

Squadra Martino will field five cars in this year’s TCR South America series, with the team benefitting from increased backing from Honda Argentina as it enters under the banner of Honda YPF Racing in ...